As the use of weight loss medications including glucagon-like peptide 1 receptor agonists grows rapidly, physicians are still figuring out how the medications might interact with other medications, including anesthesia.
Author: Claire Wallace
Nashville-based HCA Healthcare has proposed a new ASC in Hanover, Va., in the same spot where the system proposed a new hospital one year ago, according to a Feb. 1 report from Richmond Bizsense.
U.S. companies saw the highest level of job cuts in January since early 2023 and the lowest planned hiring level for the month since 2009, according to a Feb. 1 report from CNBC.
Medical device company Centinel Spine saw its Prodisc total disc replacement sales grow 56% in the ASC setting between 2022 and 2023.
Daytona Beach, Fla.-based Halifax Health plans to open a new medical office building in Port Orange, Fla., by the end of 2024, according to a Jan. 31 report from the Daytona Beach News-Journal.
Philips has earned FDA clearance for its new transesophageal echocardiography ultrasound transducer, the X11-4t Mini 3D TEE, a minimally invasive option for cardiac patients.
Glucagon-like peptide 1 receptor agonists are rapidly growing in popularity, with prescriptions for Ozempic and similar drugs quadrupling in less than three years, according to a September report from The Washington Post.
New York City-based NYU Langone Health has opened a 260,000-square-foot ambulatory center in Garden City, N.Y., in a former Bloomingdale's and Sears building, according to a Jan. 31 report from the Commercial Property Executive.
Global manufacturer and distributor Cardinal Health has acquired Specialty Networks, a technology-enabled group purchasing and practice enhancement organization, for $1.2 billion.
Medtech company Stryker has reported an 11.1% increase in net sales for 2023, reaching $20.5 billion.
